from the Managed Care Outcomes project. American Journal of Managed Care 2(3):253–264.

Hueston, W.J., A.G. Mainous, N. Brauer, and J. Mercuri. 1997. Evaluation and treatment of respiratory infections: Does managed care make a difference? Journal of Family Practice 44:261–265.

IOM (Institute of Medicine). 1992. Emerging Infections: Microbial Threats to Health in the United States. Washington, D.C.: National Academy Press.

IOM. 1997a. Managing Managed Care: Quality Improvements in Behavioral Health. M. Edmunds, R. Frank, M. Hogan, D. McCarty, R. Robinson-Beale, and C. Weisner, eds. Washington, D.C.: National Academy Press.

IOM. 1997b. Orphans and Incentives: Developing Technologies to Address Emerging Infections. Workshop Report. Washington, D.C.: National Academy Press.

IOM. 1998. Antimicrobial Resistance: Issues and Options. Workshop Report. Washington, D.C.: National Academy Press.

IOM. 1999. Extending Medicare Reimbursement in Clinical Trials. Washington, D.C.: National Academy Press.


Kizer, K.W. 1997. The veterans healthcare system: Preparing for the twenty-first century. Hospital and Health Services Administration 42(3):283–298.

Kizer, K.W. 1999. The new VA: A national laboratory for health care quality management. American Journal of Medical Quality 14(1):3–20.

Kralovic, S.M., G.A. Roselle, L.H. Danko, L.A. Simbartl, and K.W. Kizer. 1999. Hepatitis C virus antibody (HCAb) positivity in Department of Veterans Affairs (VA) facilities. In 9th Annual Meeting of the Society of Healthcare Epidemiology of America, April 18–20, 1999.

Kunzi, S.G. 1999. National drug formularies. Pharmaceutical Executive 19(4):80–90.

Kuttner, R. 1998. Must good HMOs go bad? First of two parts: The commercialization of prepaid group health care. New England Journal of Medicine 338:1558–1563.


Levine, V.R. 1998. Epidemiology of AIDS and tuberculosis among United States veterans. International Journal of Tuberculosis and Lung Disease 2(5):405–412.

Levy, R.A. and D.L. Cocks. 1996. Component Management Fails to Save Health Care System Costs: The Case of Restrictive Formularies. Reston, Va.: National Pharmaceutical Council.


Miller, R.H., and H.S. Luft. 1994. Managed care plan performance since 1980: A literature analysis. Journal of the American Medical Association 19:1512–1519.

Moy, E., A.J. Mazzaschi, R.J. Levin, D.A. Blake, and P.F. Griner. 1997. Relationship between National Institutes of Health research awards to US medical schools and managed care market penetration. Journal of the American Medical Association 278(3):217–221.


Paladino, J.A., H.F. Sperry, J.M. Backes, J.A. Gelber, D.A. Serrianne, T.J. Cumbo, and J.J. Schentag. 1991. Clinical and economic evaluations of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. American Journal of Medicine 91:462–470.


Rifenburg, R.P., S.C. Hanson, J.A. Tuttle, J.A. Paladino, and J.J. Schentag. 1996. Use of benchmarking techniques to analyze the strategies hospitals use to control antibiotic expenditures. American Journal of Health-System Pharmacy 53:2054–2062.

Roselle, G.A., S.M. Kralovic, S.E. Dane, L.A. Simbartl, L.H. Danko, and K.W. Kizer. 1999. A Department of Veterans Affairs computerized national surveillance system. In 9th Annual Meeting of the Society for Healthcare Epidemiology of America, April 18–20, 1999.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement